Skip to main content
CDC Website

At Risk Persons

At Risk Persons

Drug-Resistant Gonorrhea: An Urgent Public Health Issue

This animation details the history of drug-resistant gonorrhea in the United States, the dangers of untreatable gonorrhea, and why this issue must remain a top public health priority.

Louisiana’s Health Hub 

The goal of Louisiana's STD/HIV Program (SHP) is to educate citizens regarding STD/HIV prevention, to monitor disease trends, and to offer client-centered services.

Reducing Syphilis Rates: A Healthcare Provider's Role

This video walks healthcare providers through the three key actions that they can take to help reverse the rising syphilis rates: Talk, Test, and Treat.

Got It Covered SD

Their goal is to provide an ongoing, interactive, and open place for users to exchange resources, ideas, information and comments regarding sexual health and facts about sexually transmitted diseases (STDs).

SyphAware

A public transit campaign developed by the Oregon Health Authority for the city of Portland with ads for buses, trains and light rail cars along with a website promoting information on syphilis prevention.

MSM Sexual Health Standards of Care

New screening standards that illustrate the highest quality of sexual health care for MSM, expanding beyond federal guidelines to incorporate the collective experience of experts in the field of sexual health.

Third Trimester Pregnancy Screening for Syphilis and HIV

This information sheet highlights syphilis and HIV screening practices for pregnant women. The Centers for Disease Control and Prevention (CDC) recommends prenatal testing for syphilis and HIV during a woman’s first prenatal visit and repeat testing for “high-risk” mothers during the third trimester (preferably 28-32 weeks).

Strategies and Incentives from Health Plans to Increase Chlamydia Screening Rates

This slide set covers an array of incentives that can be provided by providers to increase chlamydia screening rates.

HIV and Injection Drug Use Syringe Services Programs for HIV Prevention

This Vital Signs highlights the importance of expanding access to SSPs, which provide sterile needles and syringes and ideally offer many other comprehensive services to help improve the health of PWID and their communities, such as treatment for substance use disorder, HIV, and hepatitis testing and linkage to treatment, and safe disposal of used syringes.

Lo que usted debe saber sobre su medicamento para la infección latente de tuberculosis (TB) – Isoniazid y Rifapentine

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.